Researchers have established a preliminary reference interval for plasma symmetric dimethylarginine in clinically healthy pet bearded dragons (Pogona vitticeps), reporting an overall mean concentration of 0.45 ± 0.16 µmol/L and a calculated reference range spanning 0.2 to 0.9 µmol/L.
Published in Frontiers in Veterinary Science under Zoological Medicine, the investigation aimed to deliver the first evaluation of symmetric dimethylarginine concentrations in clinically healthy bearded dragons and establish reference intervals while evaluating potential associations with standard indicators of renal function.
The study cohort comprised 38 adult clinically healthy bearded dragons, consisting of 18 males and 20 females. All animals evaluated in the research were maintained under standardized husbandry conditions prior to sample collection.
Plasma symmetric dimethylarginine concentrations were measured using a validated automated chemistry analyzer. Alongside this potential renal biomarker, circulating uric acid and additional biochemical analytes were analyzed concurrently in each subject.
Statistical evaluations revealed no significant difference in symmetric dimethylarginine concentrations between male and female bearded dragons, yielding a p-value of 0.2664. Furthermore, no significant correlation emerged between symmetric dimethylarginine and uric acid concentrations (r = −0.17, p = 0.3063), nor between the biomarker and the calcium-to-phosphorus ratio (r = −0.24, p = 0.1470).
The authors concluded that this research provides foundational baseline data and establishes an initial reference interval for symmetric dimethylarginine in healthy bearded dragons without showing significant associations with uric acid or the calcium-to-phosphorus ratio, noting that future studies should evaluate the diagnostic utility of the marker in clinical renal disease.
Subject of Research: Plasma symmetric dimethylarginine reference interval in clinically healthy bearded dragons
Article Title: Evaluation of and a preliminary reference interval for plasma symmetric dimethylarginine in clinically healthy pet bearded dragons (Pogona vitticeps)
Article References: Hetterich, J., Leineweber, C., Marschang, R. E., Kopp, J. S., Müller, E., & Pees, M. (2026). Evaluation of and a preliminary reference interval for plasma symmetric dimethylarginine in clinically healthy pet bearded dragons (Pogona vitticeps). Frontiers in Veterinary Science, 13, Article 1962861. https://doi.org/10.3389/fvets.2026.1962861
Image Credits: AI Generated
DOI: 10.3389/fvets.2026.1962861
Keywords: symmetric dimethylarginine, SDMA, Pogona vitticeps, bearded dragons, renal biomarker, renal disease, kidney disease, uric acid, calcium-to-phosphorus ratio, reference interval, automated chemistry analyzer, plasma SDMA, standardized husbandry, lizard, reptile, zoological medicine
News Source: Jerry Hayes. (November 19, 2026). Preliminary Plasma SDMA Reference Interval Established for Healthy Pet Bearded Dragons. Scienmag.



